This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by de Larrañaga, G F Articles by Alonso, B S Search for Related Content PubMed PubMed Citation Articles by de Larrañaga, G F Articles by Alonso, B S Social Bookmarking                         What's this?

High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity

Section of Biochemistry, Thrombosis and Haemostasis, Hospital of Infectious Diseases FJ Muñiz, Buenos Aires, Argentina; G de Larran Antiphospholipid antibodies in leprosy GF de Larrañaga Section Bioquímica-Hemostasia y Trombosis, Hospital de Enfermedades Infecciosas ‘FJ Muñiz’, Uspallata 2272, (1282) Buenos Aires, Argentina; gabyl{at}infovia.com.ar

R R Forastiero

M E Martinuzzo

L O Carreras

Division of Haematology, Favaloro University, Favaloro Foundation, Buenos Aires, Argentina

G Tsariktsian

M M Sturno

Section of Dermatology, Hospital of Infectious Diseases FJ Muñiz, Buenos Aires, Argentina

B S Alonso

Section of Biochemistry, Thrombosis and Haemostasis, Hospital of Infectious Diseases FJ Muñiz, Buenos Aires, Argentina

Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that b₂ glycoprotein I (b₂GPI) and prothrombin are the main proteins to which autoimmune aPL bind. The aim of this study was to evaluate the prevalence of different aPL in patients with leprosy. We included 51 outpatients (42 lepromatous and 9 borderline leprosy) without any clinical feature of the antiphospholipid syndrome (APS). 35 had lupus anticoagulant and 31 had anticardiolipin antibodies (aCL). Anti-ß2GPI antibodies were highly positive in 29=51 and anti-prothrombin antibodies (anti-II) were detected in 23=51. Almost all aCL and anti-b₂GPI were of IgM isotype, while IgG isotype was more frequent among anti-II. No statistical difference was found when aPL were evaluated in patients grouped according to their bacteriological status. Furthermore, patients under treatment (n ‘ 33) had a similar frequency of positive aPL compared to patients in vigilance (n ‘ 14). Assessing the specificity of antibody binding to CL and b₂GPI in ELISA by means of inhibition studies with cardiolipin-b₂GPI liposomes, leprosy and APS sera showed a similar behaviour. Comparable results were also found in both groups of patients when inhibition experiments with lysate of Mycobacterium leprae were carried out. In summary, leprosy-related aPL resemble those found in patients with APS but the immunoglobulin isotype is different, with IgM much more prevalent in leprosy patients.

Key Words: leprosy • lupus anticoagulant • antiphospholipid antibodies • anticardiolipin antibodies • anti-ß2 glycoprotein I antibodies

Lupus, Vol. 9, No. 8, 594-600 (2000)
DOI: 10.1191/096120300678828712


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Giannakopoulos, F. Passam, Y. Ioannou, and S. A. Krilis How we diagnose the antiphospholipid syndrome Blood, January 29, 2009; 113(5): 985 - 994. [Abstract] [Full Text] [PDF]

				R R Forastiero, M E Martinuzzo, and G F de Larranaga Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies Lupus, February 1, 2005; 14(2): 129 - 136. [Abstract] [PDF]

				S Loizou, S Singh, E Wypkema, and R A Asherson Anticardiolipin, anti-{beta}2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease Ann Rheum Dis, November 1, 2003; 62(11): 1106 - 1111. [Abstract] [Full Text] [PDF]